Mesothelioma (Part G)
specificA preinvasive mesothelial neoplasm that arises on the surfaces that contain mesothelial lining (pleura, peritoneum, pericardium, and tunica vaginalis) and is characterized by the proliferation of mesothelial cells in a single layer without invasion into underlying tissues. It requires demonstration of nuclear BAP1 loss or cytoplasmic MTAP loss by immunohistochemistry, or CDKN2A homozygous deletion by FISH. It is a precursor lesion to malignant mesothelioma, it most often affects the pleura, and
4
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Mesothelioma (Part G)(4)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive High-Volume Research Center | 70.0 |
| 2 | NCI Comprehensive Active Research Program | 65.0 |
| 3 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 60.0 |
| 4 | Boston University Cancer CenterBoston, MA | 55.0 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →